Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease

Background/AimsInfliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response and outcomes. Maintenance of optimal therapeutic IFX concentrations is important for sustai...

Full description

Bibliographic Details

Published in:	Gut and Liver
Main Authors:	So Yoon Choi, Ben Kang, Yon Ho Choe
Format:	Article
Language:	English
Published:	Gastroenterology Council for Gut and Liver 2019-09-01
Subjects:	infliximab drug monitoring pediatric inflammatory bowel disease
Online Access:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl18129